INDIANAPOLIS AP - Drugmaker Eli Lily and Co. said a federal court judge upheld a patent protecting one of its best-selling drugs, the cancer treatment Alimta.A trial on the drug's compound patient, which protects its chemical makeup, started Nov. 8 and ended Monday with a ruling from the U.S. District Court for the District of Delaware, Lilly said.
November 16, 2010 at 12:00 AM
1 minute read
INDIANAPOLIS AP – Drugmaker Eli Lily and Co. said a federal court judge upheld a patent protecting one of its best-selling drugs, the cancer treatment Alimta.
A trial on the drug’s compound patient, which protects its chemical makeup, started Nov. 8 and ended Monday with a ruling from the U.S. District Court for the District of Delaware, Lilly said.
Presented by BigVoodoo
The Daily Report is honoring those attorneys and judges who have made a remarkable difference in the legal profession.
This conference aims to help insurers and litigators better manage complex claims and litigation.
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
McCarter & English is actively seeking a 5th-6th year trademark associate who has trademark prosecution, licensing and litigation experi...
DESCRIPTION: The Metropolitan Transportation Authority ( MTA ) hereby solicits proposals from law firms, including sole practitioners, to pr...
The Partners Group is currently recruiting a VP of Legal for our burgeoning client, a real estate investment firm in Atlanta, GA. The firm h...
